Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo-controlled trial
Authors:
- Angela Puente SanchezASAngela Puente Sanchez
- Fanny TuronFTFanny Turon
- Javier MartinezJMJavier Martinez
- Jose Ignacio ForteaJFJose Ignacio Fortea
- Manuel Hernandez-GuerraMHManuel Hernandez-Guerra
- Edilmar Alvarado-TapiasEAEdilmar Alvarado-Tapias
- Monica PonsMPMonica Pons
- Marta MagazMMMarta Magaz
- Elba LlopELElba Llop
- Carmen Álvarez-NavascuésCÁCarmen Álvarez-Navascués
- José Castellote AlonsoJAJosé Castellote Alonso
- Marina BerenguerMBMarina Berenguer
- 20 July 2023
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 78, S2-S3